FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to pharmaceutical industry, in particular to medication for treatment of purulent wounds by method of photodynamic therapy. Medication for treating purulent wounds by method of photodynamic therapy in form of gel, which includes zinc polycholinyl phthalocyanine, hydroxyethylcellulose, dimethylsulfoxide or benzalconium chloride (alkylbenzyldimethylammonium chloride), block-copolymer of ethylene oxide and propylene oxide or polyethyleneglycol, water, taken in specified quantity. Medication for treatment of purulent wounds by method of photodynamic therapy, representing film, obtained by drying of gel described above.
EFFECT: medication is convenient in application and ensures healing of purulent wounds in minimal possible terms.
2 cl, 4 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
COMPOSITION FOR FLUORESCENT DIAGNOSTICS AND PHOTODYNAMIC THERAPY | 2008 |
|
RU2379026C2 |
PHOTOSENSITISERS FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2536966C1 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2549953C2 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2012 |
|
RU2479585C1 |
PHOTOSENSITISER FOR PHOTODYNAMIC THERAPY | 2013 |
|
RU2548726C2 |
METHOD FOR IDENTIFICATION OF OPTIMAL MODES OF FLUORESCENT DIAGNOSTICS AND PHOTODYNAMIC THERAPY | 2008 |
|
RU2376044C1 |
AGENT FOR THE TREATMENT OF PURULENT WOUNDS BY THE METHOD OF ANTIMICROBIAL PHOTODYNAMIC THERAPY | 2018 |
|
RU2678974C1 |
PREPARATION FOR PHOTODYNAMIC THERAPY AND METHOD FOR PHOTODYNAMIC THERAPY OF CANCER WITH USING IT | 2012 |
|
RU2521327C1 |
METHOD OF ORGAN-PRESERVING TREATMENT OF PATIENTS WITH INITIAL CARCINOMA OF VULVA | 2010 |
|
RU2445991C2 |
METHOD OF OPTIMISATION OF PHOTODYNAMIC THERAPY OF PURULENT WOUNDS (VERSIONS) | 2015 |
|
RU2609735C1 |
Authors
Dates
2012-11-10—Published
2011-06-01—Filed